The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate ...

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

The Federal Trade Commission has moved to block Edwards Lifesciences’ proposed acquisition of medical-device company JenaValve Technology.The FTC said in a complaint filed Wednesday the acquisition ...

FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

JenaValve Technology announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition by Edwards Lifesciences. JenaValve respectfully disagrees with the ...

The Federal Trade Commission filed a lawsuit to prevent Edward LifeSciences from acquiring JenaValve Technology, arguing the deal would stifle innovation in treatments for aortic regurgitation, a ...

Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition of JenaValve Technology.

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...